View this message in your internet browser.
—A Complimentary Webinar from Millennium Research Group
Breast cancer screening programs are helping drive global breast biopsy device markets. As a greater number of suspicious lesions are identified through screening, the number of lesions that require a biopsy to determine malignancy increases.
In addition, clinicians are shifting away from open surgical breast biopsy procedures and toward minimally invasive procedures such as vacuum-assisted biopsy, core needle biopsy or fine needle aspiration. Within the various types of minimally invasive procedures, different geographic regions are showing differing preferences based on availability, diagnostic accuracy and culture.
Please join us for an in-depth analysis of this market within the context of our new report:
Global Markets for Breast Biopsy Devices 2013
Request more information about this webinar.
Our Analyst, Michelle Chan, will cover the following topics:
How Will Screening and Shifts within MI Procedures Drive the Global Breast Biopsy Device Market?
Register for MRG’s COMPLIMENTARY webinar.
The webinar will take place on February 12, 2013 at 11:00 am US Eastern Time, 8 am US Pacific Time, 5 pm Central European Time (Paris).
Aline Nouh | +1 (416) 364-7776 x392 | email@example.com
© Millennium Research Group, Inc. All rights reserved.